Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Transplant Cell Ther. 2021 Feb 25;27(6):476.e1–476.e7. doi: 10.1016/j.jtct.2021.02.018

Figure 1. Hematology following 211At-anti-CD45 mAb conditioning with 9.2Gy TBI.

Figure 1.

All dogs experienced neutropenia, lymphocytopenia, and thrombocytopenia with a median neutrophil nadir of 20 cells/μ L, median lymphocyte nadir of 18 cells/μ L and median platelet nadir of 4.5 × 103/μ L.